Quality Chemical Industries Limited (UGSE:QCIL)

Market Cap	423.62B
Revenue (ttm)	263.07B
Net Income (ttm)	42.47B
Shares Out	3.65B
EPS (ttm)	11.63
PE Ratio	9.97
Forward PE	n/a
Dividend	13.50 (11.64%)
Ex-Dividend Date	Nov 21, 2025

Volume	1,000
Average Volume	19,615
Open	n/a
Previous Close	115.47
Day's Range	116.00 - 116.00
52-Week Range	54.66 - 120.00
Beta	-0.16
RSI	40.11
Earnings Date	Feb 9, 2026

About UGSE:QCIL

Quality Chemical Industries Limited manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers emeset for the treatment of nausea and vomiti...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 362
• Stock Exchange: Uganda Securities Exchange
• Ticker Symbol: QCIL

Financial Performance

In 2024, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.